TY  - GEN
AU  - Gilhus,N E
AU  - Hong,Y
TI  - Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence
SN  - 1468-1331
PY  - 2019///0513
KW  - Adult
KW  - Autoantibodies
KW  - Family
KW  - Female
KW  - Humans
KW  - Immunoglobulins, Intravenous
KW  - adverse effects
KW  - Immunosuppressive Agents
KW  - Infant, Newborn
KW  - Myasthenia Gravis
KW  - drug therapy
KW  - Neuromuscular Diseases
KW  - Pregnancy
KW  - Prenatal Exposure Delayed Effects
KW  - immunology
KW  - Pyridostigmine Bromide
KW  - Receptor Protein-Tyrosine Kinases
KW  - Receptors, Cholinergic
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1111/ene.13788
ER  -